ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,01%
Bitcoin
67.626,04
0,21%
Brent Oil
81,295
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Valneva SE (VALN)

  7. Valneva SE (VALN) Notícias

VALN

Valneva (VALN)

Valneva SE
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:VALN
DataHoraFonteTítuloCódigoCompanhia
31/05/202413:23Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VALNValneva SE
14/02/202410:59Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VALNValneva SE
09/11/202320:35Dow Jones NewsFDA Approves Valneva's Chikungunya Virus VaccineNASDAQ:VALNValneva SE
21/09/202308:40IH Market NewsThursday’s Wall Street Highlights: FedEx, Broadcom, Nio, Klaviyo, Starbucks, and moreNASDAQ:VALNValneva SE
14/08/202304:55Dow Jones NewsValneva Shares Slump After FDA Postpones Chikungunya Vaccine Review DateNASDAQ:VALNValneva SE
14/08/202303:18Dow Jones NewsValneva Says FDA Has Delayed Chikungunya Vaccine Review DateNASDAQ:VALNValneva SE
30/06/202310:00Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:VALNValneva SE
22/06/202318:00Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:VALNValneva SE
04/05/202319:28Dow Jones NewsADRs End Mostly Lower; Embraer, Valneva Trade ActivelyNASDAQ:VALNValneva SE
17/02/202305:13Dow Jones NewsValneva, Pfizer to Discontinue Some Trials for Lyme Disease VaccineNASDAQ:VALNValneva SE
05/12/202206:19Dow Jones NewsValneva Shares Gain After Positive Vaccine Trial ResultsNASDAQ:VALNValneva SE
01/12/202211:35TipRanksH.C. Wainwright Sticks to Their Buy Rating for Valneva (VALN)NASDAQ:VALNValneva SE
16/11/202212:00Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:VALNValneva SE
30/09/202217:20TipRanksAnalysts Offer Insights on Healthcare Companies: Sintx Technologies (SINT), Motus Gi Holdings (MOTS) and Valneva (VALN)NASDAQ:VALNValneva SE
26/09/202210:05TipRanksH.C. Wainwright Sticks to Its Buy Rating for Valneva (VALN)NASDAQ:VALNValneva SE
19/09/202206:57TipRanksValneva (NASDAQ:VALN) Slides on Ending COVID-19 Vaccine CollaborationNASDAQ:VALNValneva SE
08/09/202210:25TipRanksH.C. Wainwright Keeps Their Buy Rating on Valneva (VALN)NASDAQ:VALNValneva SE
08/09/202202:00Business WireValneva and VBI Vaccines Announce European Partnership for Marketing and Distribution of PreHevbri®NASDAQ:VALNValneva SE
24/08/202209:15TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Valneva (VALN)NASDAQ:VALNValneva SE
22/08/202207:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VALNValneva SE
18/08/202210:20TipRanksAnalysts’ Top Healthcare Picks: Curis (CRIS), Valneva (VALN)NASDAQ:VALNValneva SE
12/08/202217:43Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:VALNValneva SE
12/08/202207:03Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)NASDAQ:VALNValneva SE
08/08/202218:36Dow Jones NewsPfizer, Valneva Initiate Phase 3 Study of Lyme Disease Vaccine VLA15NASDAQ:VALNValneva SE
08/08/202217:45Business WirePfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15NASDAQ:VALNValneva SE
03/08/202207:15TipRanksAnalysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Valneva (VALN)NASDAQ:VALNValneva SE
20/07/202218:55Dow Jones NewsADRs End Lower; Valneva, Tokio Marine Trade ActivelyNASDAQ:VALNValneva SE
27/06/202209:28TipRanksAnalysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM) and Valneva (VALN)NASDAQ:VALNValneva SE
20/06/202208:28TipRanksHere’s What Pfizer & Valneva Announced on MondayNASDAQ:VALNValneva SE
20/06/202202:00Business WireValneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15NASDAQ:VALNValneva SE
 Apresentando as notícias mais relevantes sobre:NASDAQ:VALN

Seu Histórico Recente

LSE
FJ19
East.power 43
CSE
WRLD.U
ICC International Cannabis
TSX
AGF.B
AGF Management
BIT
UR9ZNC
UniCredit Bank
LSE
77ZK
Investec Bnk 26
NASDAQ
NTSP
BIT
IKOR
Exchange Trading Funds
LSE
SPI
Spire Healthcare
NASDAQ
LJAQW
LightJump Acquisition
BIT
UC4WF9
Unicredit Bank
BIBX
UPPBTC
Sentinel Protocol
BIT
UB4Q5R
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados